Can I Buy Moderna Inc Shares in India?

Yes, Moderna Inc shares can be bought in India by opening an international trading account with Groww.

How to Buy Moderna Inc Shares in India?

One can easily invest in Moderna Inc shares from India by: Direct Investment - Opening an international trading account with Groww which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Moderna Inc shares. Indirect Investment - Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Moderna Inc.

What is the Share Price of Moderna Inc?

The share price of Moderna Inc is in Dollars and if you are investing from India, you can always check the INR valuation before investing. The current Moderna Inc share price is $41.70 as of 14 Dec ‘24

What is the Market Cap of Moderna Inc?

The Moderna Inc market cap is $16.09B as of 14 Dec ‘24

What is the PE and PB ratio of Moderna Inc?

The PE and PB ratio of Moderna Inc is -7.2 and 1.3 as of 14 Dec ‘24

Moderna Inc Share Price, MRNA Stock Price Quote Today

<img alt="Moderna Inc" srcSet="https://viewlogo.s3.amazonaws.com/61026/conversions/596427-default.png 1x, https://viewlogo.s3.amazonaws.com/61026/conversions/596427-default.png 2x" src="https://viewlogo.s3.amazonaws.com/61026/conversions/596427-default.png" decoding="async" data-nimg="intrinsic" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" class="companyLogo_companyImage__bT0On absolute-center uspp14Logo" loading="lazy"/>
Moderna Inc Healthcare 
$41.70
-1.12(2.62%) 1D
1D
1W
1M
1Y
3Y
5Y
Performance
Open PricePrev. CloseVolumeAvg. Volume
$42.24$42.824,857,4089,404,623
FundamentalsMarket Cap$16.09B
P/B Ratio1.3
P/E Ratio-7.2
Enterprise Value$15.75B
Div. Yield0.00%
Book Value35.31
EPS(TTM)-9.10
ROE-20.30%
Understand Fundamentals
FUNDAMENTALS
It is financial information that is reported quarterly or annually.
Market Cap
Market cap or market capitalization is the total market value of all of a company's outstanding shares.
Div. Yield
The divided yield displayed as a percentage is the amount of money a company pays shareholders for owning a share of its stock divided by its current stock price
P/B Ratio
The price-to-book ratio is a company's current market price to its Book Value. Traditionally, any value under 1.0 is considered a good P/B value, indicating a potentially undervalued stock.
Book Value
The book value of a stock is theoretically the amount of money that would be paid to shareholders if the company was liquidated and paid off all of its liabilities.
P/E Ratio
The price-earnings ratio is a company's share price to the company's Earnings per Share. The ratio is used for evaluating companies and to find out whether they are overvalued or undervalued.
EPS(TTM)
Earnings per share (EPS) is a company's net profit divided by the number of common shares it has outstanding. EPS indicates how much money a company makes for each share of its stock, and is widely used metric to estimate corporate value
Enterprise Value
Enterprise Value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
ROE
Return on equity (ROE) is a measure of financial performance calculated by dividing net income by shareholder's equity
About the CompanyModerna, Inc. is an American pharmaceutical and biotechnology company that is based in Cambridge, Massachusetts, and was established in the year 2010. The company essentially focuses on vaccine technologies that are based on messenger RNA. The vaccine platform of the company inserts synthetic nucleoside-modified messenger RNA into human cells using a coating of lipid nanoparticles. Moderna, Inc. was a company that was formed to commercialize the research of stem cell biologist Derrick Rossi. The company is known to play a crucial role in human biology, transferring the instructions that are stored in the DNA to make what is currently required for the living cell. They play a role in the prevention, treatment, and cure of diseases. The company has also begun the study of the influenza vaccine and has also received the US FDA fast track designation for the respiratory syncytial virus (RSV) vaccine. The company also has 24 vaccine candidates that include vaccine candidates for influenza, HIV, the Nipah Virus, and a second COVID-19 vaccine that would be easier to store and administer than existing vaccines.;
OrganisationModerna Inc
IndustryBiotechnology
HeadQuartersCambridge, MA
Company Financials
*All values are in Million $
No Graph Data To Display
Quarterly
Yearly
See Details
Similar StocksCOMPANYMARKET PRICECLOSE PRICEMARKET CAP

Vaishnavi Tech Park, 3rd & 4th Floor
Sarjapur Main Road, Bellandur
Bengaluru – 560103
Contact Us
PRODUCTS
StocksFutures & OptionsMTFIPOMutual FundsNFOETFCreditBill Payments
GROWW
About UsPricingBlogMedia & PressCareersHelp and SupportTrust and Safety
QUICK LINKS
AMC Mutual FundsCalculatorsGlossaryOpen Demat AccountGroww DigestSitemapWeb Stories
ⓒ 2016-2024 Groww. All rights reserved, Built with ♥in India

Open Price	Prev. Close	Volume	Avg. Volume
$42.24	$42.82	4,857,408	9,404,623

Market Cap	$16.09B
P/B Ratio	1.3
P/E Ratio	-7.2
Enterprise Value	$15.75B

Organisation	Moderna Inc
Industry	Biotechnology
HeadQuarters	Cambridge, MA